Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets.
about
Erythrocyte-derived ATP and perfusion distribution: role of intracellular and intercellular communicationCyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapyRole of endothelium-derived nitric oxide in the regulation of blood pressureRole of von Willebrand factor in tumour cell-induced platelet aggregation: differential regulation by NO and prostacyclinA human platelet calcium calculator trained by pairwise agonist scanningMaresin 1 induces a novel pro-resolving phenotype in human plateletsOf reductionism and the pendulum swing: connecting toxicology and human health.Formation of S-nitrosothiols from regiospecific reaction of thiols with N-nitrosotryptophan derivatives.Pharmacology of endothelium-derived nitric oxide and nitrovasodilators.Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cellsUrinary nitrate excretion is increased in patients with rheumatoid arthritis and reduced by prednisolone.Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseasesNG-methyl-L-arginine causes endothelium-dependent contraction and inhibition of cyclic GMP formation in artery and veinAn L-arginine/nitric oxide pathway present in human platelets regulates aggregation.Potential therapeutic action of nitrite in sickle cell diseaseEndothelial nitric oxide in humans in health and disease.NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties.PPAR agonists as direct modulators of the vessel wall in cardiovascular disease.Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusionInhibitory effect of nitrite on coagulation processes demonstrated by thrombelastography.C-type natriuretic peptide inhibits leukocyte recruitment and platelet-leukocyte interactions via suppression of P-selectin expression.A nanoparticle delivery vehicle for S-nitroso-N-acetyl cysteine: sustained vascular responseIn vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols.Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factorAngiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.The mechanisms for nitration and nitrotyrosine formation in vitro and in vivo: impact of diet.Reactive oxygen intermediates involved in cellular regulation.Adventures in vascular biology: a tale of two mediators.Endothelium-dependent vascular responses. Mediators and mechanismsTemporal and pharmacological characterization of angiostatin release and generation by human platelets: implications for endothelial cell migration.The pathogenesis of diabetic retinopathy: old concepts and new questions.Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.Antiplatelet effect of the anaesthetic drug propofol: influence of red blood cells and leucocytes.Inhibition of human platelet aggregation by a novel S-nitrosothiol is abolished by haemoglobin and red blood cells in vitro: implications for anti-thrombotic therapyProstacyclin prevents nitric oxide-induced megakaryocyte apoptosisThe 1991 Ulf von Euler Lecture. The L-arginine: nitric oxide pathway.S-nitrosoglutathione inhibits platelet activation and deposition in coronary artery saphenous vein grafts in vitro and in vivoEndothelium-mediated control of vascular tone: COX-1 and COX-2 products.Gene therapy for vascular diseases.Endothelial injury, vasoconstriction, and its prevention.
P2860
Q24598135-61681F7B-FC36-475A-AC60-94D8BE3C881AQ24675327-F122494A-3F7C-48A0-8350-D6A005424816Q28242958-D3CC6E15-A505-4A1E-A095-F07E736E6C79Q28362757-39490297-C932-4EF0-B818-BCE1E1C7839FQ28543697-047EEE2E-FC63-47AE-8A10-FCE13D34158AQ29248094-20D1C26A-0F57-41BC-AACB-AE2024B9A887Q30395151-C2C9183F-7BF8-4ED8-B4A6-78FE185CFE6FQ30952040-E63400FD-9203-4B6C-B16F-C0B0A099BAC0Q33558813-BF05AEC0-6366-41F6-B26B-E30D85FAAD0DQ33567885-E22DE43F-D090-42C5-8AB8-0602994F2484Q33578415-807DE555-6C8D-4B3F-AB77-F5C5A5B6C794Q33584105-8B99CFA4-F785-44E9-892D-27DC23891276Q33625854-1D8DDBFE-C597-4E5D-9AA5-1BA61E00A3DAQ33674149-FA43DE5A-03DC-4D69-AFDC-C87549DC6F46Q33681568-59E262EE-A5C3-45B5-A839-F202E279664FQ33815804-3A6C5E5B-D2DD-416E-BF6C-F6ADE6476C5BQ33896104-6AA7EB56-733A-42DE-8F60-44346BA46987Q33996831-ECA07CCA-0001-4106-B6D4-E26932EA66A3Q34024896-570DF43B-CCC4-4875-97E2-B39EB5D01C57Q34047105-DA2CAD1B-5687-4582-BEAC-193C017A9C38Q34063537-A9CC155F-D424-4587-86A9-ADFB1AEC656CQ34141284-52854A74-56FE-4F84-895B-C5EE7C6C5DF6Q34188808-45A5AA57-AFFD-4632-BB08-652AD3E3648FQ34298013-7CC301A1-4D85-4A81-847B-9B9AA6F116CAQ34378188-77181661-54AA-4041-B566-528AAD1241CBQ34430046-D5FE9379-3A01-4322-B6F2-4C738F92C21DQ34455919-353FC2D4-788B-4AC6-9D6A-9A7F9E9C5BD9Q34515584-71D215D4-5630-4B89-99C5-EEFB13F647B4Q34578188-BFC7F5FC-577F-46AE-8E12-C099920974EFQ34648936-A34C66FB-F442-4E72-BFFA-A2333F7D0FB1Q34658478-E658BDB0-5217-44EE-B2A8-F65D0EF0CFC0Q35026005-DAF08033-9BE5-421D-9A19-3E8243966781Q35041737-9629D374-6023-4141-96D5-52D3A6B595F9Q35042989-A95A3A40-3247-475B-A0BA-D77886EFA459Q35048911-A20C04E2-23C5-4B15-96EC-4E559EE10AC9Q35335352-904CD807-D0BA-4125-AFF5-6D2F90A64046Q35368647-FCF6E54C-4E03-462E-9770-A85102F4128CQ35376020-F64F9937-9F14-40FE-81B4-966D820450AEQ35652189-2898A3EA-9622-4C3B-A6F9-F4FF783291FAQ35655775-14139813-0096-4CEF-A7C5-5840162BB937
P2860
Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Comparative pharmacology of en ...... and prostacyclin in platelets.
@en
Comparative pharmacology of en ...... and prostacyclin in platelets.
@nl
type
label
Comparative pharmacology of en ...... and prostacyclin in platelets.
@en
Comparative pharmacology of en ...... and prostacyclin in platelets.
@nl
prefLabel
Comparative pharmacology of en ...... and prostacyclin in platelets.
@en
Comparative pharmacology of en ...... and prostacyclin in platelets.
@nl
P2093
P2860
P1476
Comparative pharmacology of en ...... and prostacyclin in platelets.
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.1987.TB11310.X
P407
P577
1987-09-01T00:00:00Z